How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

26,277 results for

breast NOT cancer

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Breast screening: breast implant guidelines

Breast screening: breast implant guidelines Breast screening: breast implant guidelines - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Promotional material Breast screening: breast implant guidelines This leaflet (...) provides information about NHS breast screening for women with breast implants. Published 1 June 2010 Last updated 1 October 2019 — From: Documents If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. HTML Details Healthcare professionals can use this information to tell women about how breast implants affect screening

2019 Public Health England

2. Breast Magnetic Resonance Imaging for Breast Implant Associated Anaplastic Large Cell Lymphoma

Breast Magnetic Resonance Imaging for Breast Implant Associated Anaplastic Large Cell Lymphoma 1 Minutes from MSAC Executive Meeting, 29 September 2017 Application 1490 – Breast Magnetic Resonance Imaging (MRI) for Breast Implant Associated Anaplastic Large Cell Lymphoma MSAC Executive advice to the Minister In the context of a rare disease with limited data, the MSAC Executive agreed to an expedited MSAC assessment and supported the MBS listing of MRI of the breast for patients who have been (...) diagnosed with breast implant associated anaplastic large cell lymphoma (BIA-ALCL) based on acceptable safety and clinical effectiveness with an MBS fee of $690. Summary of consideration and rationale for MSAC Executive’s advice The MSAC Executive noted that the Department received an application for breast MRI for BIA- ALCL which was considered by PASC at its meeting on 11 August 2017. PASC referred this application to the MSAC Executive for advice on an appropriate assessment pathway. The MSAC

2019 Medical Services Advisory Committee

3. Breast screening: GE Healthcare Senographe Pristina DBT System

Breast screening: GE Healthcare Senographe Pristina DBT System Breast screening: GE Healthcare Senographe Pristina DBT System - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Coronavirus guidance is being updated. Read Stay alert. Control the virus. Save lives. Guidance Breast screening (...) : GE Healthcare Senographe Pristina DBT System Practical evaluation of GE Healthcare Senographe Pristina digital breast tomosynthesis system used in the NHS breast screening programme. Published 21 April 2020 From: Documents Ref: PHE publications gateway number: GW-1125 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you

2020 Public Health England

4. Breast screening: organising very high risk (VHR) screening

Breast screening: organising very high risk (VHR) screening Breast screening: organising very high risk (VHR) screening - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Breast screening: organising very high risk (VHR) screening Information for breast (...) screening service staff about how to organise very high risk (VHR) screening as part of the NHS Breast Screening Programme (NHS BSP). Published 1 March 2013 Last updated 8 September 2020 — From: Documents Ref: PHE publications gateway number GW-1546 HTML Details Every screening service is expected to have arrangements in place for managing women in their area who are eligible for All the with any queries about this publication, making sure you include its full title. Published 1 March 2013 Last updated

2020 Public Health England

5. Breast screening: IMS Giotto Class evaluation

Breast screening: IMS Giotto Class evaluation Breast screening: IMS Giotto Class evaluation - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Breast screening: IMS Giotto Class evaluation A evaluation of the IMS Giotto Class Full Field Digital Mammography (...) (FFDM), Digital Breast Tomosynthesis (DBT) and the biopsy facility. Published 12 August 2020 From: Documents If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This document presents a practical evaluation of the IMS Giotto Class Explore the topic Is this page useful? Thank you for your feedback Help us

2020 Public Health England

6. Breast screening: Siemens Mammomat Revelation evaluation

Breast screening: Siemens Mammomat Revelation evaluation Breast screening: Siemens Mammomat Revelation evaluation - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Breast screening: Siemens Mammomat Revelation evaluation An evaluation of the Siemens Mammomat (...) Revelation system for use in the NHS Breast Screening Programme (BSP). Published 12 August 2020 From: Documents If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details This document presents an evaluation of the Siemens Mammomat Revelation system for use in the NHS Explore the topic Is this page useful? Thank you

2020 Public Health England

7. Breast screening: Hologic 3Dimensions in tomosynthesis mode

Breast screening: Hologic 3Dimensions in tomosynthesis mode Breast screening: Hologic 3Dimensions in tomosynthesis mode - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Guidance Breast screening: Hologic 3Dimensions in tomosynthesis mode A practical evaluation (...) of the Hologic 3Dimensions mammography system in digital breast tomosynthesis mode. Published 12 August 2020 From: Documents Explore the topic Is this page useful? Thank you for your feedback Help us improve GOV.UK Don’t include personal or financial information like your National Insurance number or credit card details. What were you doing? What went wrong? Send Help us improve GOV.UK To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form

2020 Public Health England

8. Formula versus maternal breast milk for feeding preterm or low birth weight infants. (Abstract)

Formula versus maternal breast milk for feeding preterm or low birth weight infants. Artificial formula can be manipulated to contain higher amounts of macro-nutrients than maternal breast milk but breast milk confers important immuno-nutritional advantages for preterm or low birth weight (LBW) infants.To determine the effect of feeding preterm or LBW infants with formula compared with maternal breast milk on growth and developmental outcomes.We used the standard strategy of Cochrane Neonatal (...) to search the Cochrane Central Register of Controlled Trials (CENTRAL 2018, Issue 9), and Ovid MEDLINE, Ovid Embase, Ovid Maternity & Infant Care Database, and CINAHL to October 2018. We searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles.Randomised or quasi-randomised controlled trials that compared feeding preterm or low birth weight infants with formula versus maternal breast milk.Two review authors planned independently to assess trial

2019 Cochrane

9. Formula versus donor breast milk for feeding preterm or low birth weight infants. Full Text available with Trip Pro

Formula versus donor breast milk for feeding preterm or low birth weight infants. When sufficient maternal breast milk is not available, alternative forms of enteral nutrition for preterm or low birth weight (LBW) infants are donor breast milk or artificial formula. Donor breast milk may retain some of the non-nutritive benefits of maternal breast milk for preterm or LBW infants. However, feeding with artificial formula may ensure more consistent delivery of greater amounts of nutrients (...) . Uncertainty exists about the balance of risks and benefits of feeding formula versus donor breast milk for preterm or LBW infants.To determine the effect of feeding with formula compared with donor breast milk on growth and development in preterm or low birth weight (LBW) infants.We used the Cochrane Neonatal search strategy, including electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 5), Ovid MEDLINE, Embase, and the Cumulative Index to Nursing and Allied

2019 Cochrane

10. Chlorhexidine Gluconate for Skin Preparation During Stereotactic Core Biopsy of the Breast: Clinical Effectiveness and Guidelines

Chlorhexidine Gluconate for Skin Preparation During Stereotactic Core Biopsy of the Breast: Clinical Effectiveness and Guidelines Chlorhexidine Gluconate for Skin Preparation During Stereotactic Core Biopsy of the Breast: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Chlorhexidine Gluconate for Skin Preparation During Stereotactic Core Biopsy of the Breast: Clinical Effectiveness and Guidelines Chlorhexidine Gluconate for Skin Preparation During Stereotactic (...) Core Biopsy of the Breast: Clinical Effectiveness and Guidelines Last updated: February 8, 2019 Project Number: RB1309-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of chlorhexidine gluconate wipes for female adults undergoing skin preparation during stereotactic core biopsy of the breast? What are the evidence-based guidelines associated with skin preparation during stereotactic core biopsy

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

11. Povidone-Iodine for Breast Implant Surgery: A Review of Clinical Effectiveness and Guidelines

Povidone-Iodine for Breast Implant Surgery: A Review of Clinical Effectiveness and Guidelines Povidone-Iodine for Breast Implant Surgery: A Review of Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Povidone-Iodine for Breast Implant Surgery: A Review of Clinical Effectiveness and Guidelines Povidone-Iodine for Breast Implant Surgery: A Review of Clinical Effectiveness and Guidelines Last updated: May 16, 2019 Project Number: RC1120-000 Product Line: Research Type (...) : Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the comparative clinical effectiveness of povidone-iodine solutions versus other antiseptic solutions for pocket irrigation in breast implant surgery? What is the comparative clinical effectiveness of povidone-iodine solutions versus other antiseptic solutions for implant soaking in breast implant surgery? What are the evidence-based guidelines regarding the use of povidone-iodine solutions

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

12. Breast screening: IMS Giotto Class digital mammography system in 2D mode

Breast screening: IMS Giotto Class digital mammography system in 2D mode Breast screening: IMS Giotto Class digital mammography system in 2D mode - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Breast screening: IMS Giotto Class digital mammography system in 2D mode Technical evaluation of the IMS Giotto Class digital mammography system in 2D mode, used in the NHS breast screening programme. Published 8 (...) July 2019 From: Documents Ref: PHE publications gateway number GW-524 If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email . Please tell us what format you need. It will help us if you say what assistive technology you use. Details The report is one of a series of technical reports evaluating commercially available mammography systems on behalf of the NHS breast screening programme. The report will help breast

2019 Public Health England

13. Breast screening: Fujifilm Amulet Innovality DBT system evaluation

Breast screening: Fujifilm Amulet Innovality DBT system evaluation Breast screening: Fujifilm Amulet Innovality DBT system evaluation - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Breast screening: Fujifilm (...) Amulet Innovality DBT system evaluation Practical evaluation of the Fujifilm Amulet Innovality digital breast tomosynthesis system used in the NHS breast screening programme. Published 9 December 2019 Last updated 9 December 2019 — From: Documents Ref: PHE publications gateway number GW-935 9 December 2019 Updated the executive summary on page 4. 9 December 2019 First published. Related content Collection Explore the topic Is this page useful? Thank you for your feedback Help us improve GOV.UK Don’t

2019 Public Health England

14. Breast screening: Hologic 3Dimensions in 2D mode

Breast screening: Hologic 3Dimensions in 2D mode Breast screening: Hologic 3Dimensions in 2D mode - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Breast screening: Hologic 3Dimensions in 2D mode Practical (...) in 2D mode used in the NHS breast screening programme. Published 9 December 2019 Related content Collection Explore the topic Is this page useful? Thank you for your feedback Help us improve GOV.UK Don’t include personal or financial information like your National Insurance number or credit card details. What were you doing? What went wrong? Send Help us improve GOV.UK To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take

2019 Public Health England

15. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with Full Text available with Trip Pro

The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with TOMMY trial: A comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry (...) , Celia Strudley 9 , Susan M Astley 10 , Oliver Morrish 11 , Kenneth C Young 9 , Stephen W Duffy 12 1 Department of Radiology, University of Cambridge, Cambridge, UK 2 Aberdeen Biomedical Imaging Centre, University of Aberdeen, Aberdeen, UK 3 Jarvis Breast Centre, Guildford, UK 4 North East Scotland Breast Screening Centre, Aberdeen, UK 5 Breast Radiology, King’s College Hospital, London, UK 6 West of Scotland Breast Screening Service, Glasgow, UK 7 The Nightingale Centre, University Hospital South

2015 NIHR HTA programme

16. Breast Implants: Comparative Clinical Effectiveness

Breast Implants: Comparative Clinical Effectiveness Breast Implants: Comparative Clinical Effectiveness | CADTH.ca Find the information you need Breast Implants: Comparative Clinical Effectiveness Breast Implants: Comparative Clinical Effectiveness Last updated: July 27, 2018 Project Number: RB1243-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the comparative clinical effectiveness of one type of breast implant when (...) compared to another type of breast implant? Key Message Two systematic reviews, one meta-analysis, and two randomized controlled trials were identified regarding the comparative clinical effectiveness of one type of breast implant when compared to another type of breast implant. Files Rapid Response Summary of Abstracts Published : July 27, 2018 Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

18. Need milk? Domperidone for increasing breast milk supply

Need milk? Domperidone for increasing breast milk supply Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca July 8, 2019 (...) (en français) Need milk? Domperidone for increasing breast milk supply Clinical Question: What is the efficacy and safety of domperidone to increase milk supply in breastfeeding mothers? Bottom Line: In mothers of pre-term infants, domperidone increases milk volume by ~90 ml more than placebo after 14 days, with an additional 1 in 5 women experiencing a 50% increase in milk supply. Doses above 30 mg/day are likely not needed and may increase the risk of arrhythmias. Optimal length of treatment

2019 Tools for Practice

19. Reduced Pain and Accelerated Recovery Following Primary Breast Augmentation With Lightweight Breast Implants Full Text available with Trip Pro

Reduced Pain and Accelerated Recovery Following Primary Breast Augmentation With Lightweight Breast Implants The posttreatment pain associated with breast augmentation is a top concern of most patients and can affect the decision concerning surgery.This study aimed to compare the posttreatment pain and recovery times of patients undergoing primary breast augmentation with lightweight vs full-mass implants of similar volumes. The authors hypothesized that the reduced mechanical strain applied (...) by lightweight implants elicits less pain.In this retrospective, observational study, 100 women who had undergone primary breast augmentation with either a lightweight breast implant or a traditional full-mass silicone implant (n = 50), were contacted by phone and asked about their posttreatment experiences and overall satisfaction with the outcome. All women were treated by the same surgical team, and the two groups were matched by date of surgery.Most patients in the two cohorts had a self-reported

2018 Aesthetic surgery journal

20. Comparative effectiveness review of paravertebral block for prevention of chronic pain after breast surgery

Comparative effectiveness review of paravertebral block for prevention of chronic pain after breast surgery Comparative effectiveness review of paravertebral block for prevention of chronic pain after breast surgery Comparative effectiveness review of paravertebral block for prevention of chronic pain after breast surgery HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment (...) has been made for the HTA database. Citation HAYES, Inc. Comparative effectiveness review of paravertebral block for prevention of chronic pain after breast surgery. Lansdale: HAYES, Inc. Directory Publication. 2017 Authors' conclusions Patients undergoing breast surgery have a notable risk of developing persistent pain lasting for more than 3 months following the procedure. Paravertebral blocks (PVBs) may be used in breast surgery as part of anesthetic care, and have been linked to reduced acute

2018 Health Technology Assessment (HTA) Database.

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>